Walleye Trading
AGL icon

Walleye Trading’s Agilon Health AGL Stock Holding History

Walleye Trading’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-400
Closed -$6.89K – 4062
2025
Q4 		$6.89K Sell
400
-1,060
-73% -$20.6K ﹤0.01% 4184
2025
Q3 		$37.6K Buy
1,460
+484
+50% +$18.3K ﹤0.01% 4029
2025
Q2 		$56.1K Buy
+976
New +$78.3K ﹤0.01% 3793
2025
Q1 		– Sell
-464
Closed -$22K – 3995
2024
Q4 		$22K Buy
+464
New +$28.1K ﹤0.01% 3939
2024
Q3 		– Sell
-248
Closed -$40.5K – 4060
2024
Q2 		$40.5K Sell
248
-368
-60% -$52.4K ﹤0.01% 3654
2024
Q1 		$93.9K Sell
616
-980
-61% -$163K ﹤0.01% 3800
2023
Q4 		$501K Sell
1,596
-1,148
-42% -$415K ﹤0.01% 3065
2023
Q3 		$1.22M Buy
2,744
+892
+48% +$403K ﹤0.01% 2195
2023
Q2 		$803K Buy
1,852
+384
+26% +$216K ﹤0.01% 2384
2023
Q1 		$872K Buy
+1,468
New +$822K ﹤0.01% 2320

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Walleye Trading's AGL Position: Q3 2024 in Review

Walleye Trading sold out of Agilon Health (AGL) in Q3 2024, closing a stake of 273 shares — an estimated $44.6K sold.

Walleye Trading first reported a position in AGL in Q1 2023 and held it in 4 quarters. The position peaked at $886K in Q3 2023. 209 funds tracked by Wall St. Rank hold AGL as of Q3 2024.

  • Walleye Trading reported no remaining Agilon Health position as of Q3 2024 after selling out during the quarter.
  • Walleye Trading sold 273 Agilon Health shares in Q3 2024, an estimated $44.6K.
  • Walleye Trading first reported a position in Agilon Health in Q1 2023 and held it in 4 quarters.
  • Walleye Trading's Agilon Health position peaked at $886K in Q3 2023.
  • 209 funds tracked by Wall St. Rank held Agilon Health as of Q3 2024.

Based on Walleye Trading's 13F filing for Q3 2024, filed 14 Nov 2024.